Precigen, inc. (XON)

CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Cash flows from operating activities
Cash flows from operating activities
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

-317,778

-323,916

-496,423

-501,535

-529,433

-514,706

-206,929

-189,019

-141,852

-126,820

-137,787

-126,962

-157,331

-190,274

-178,637

-187,655

-179,118

-87,994

-36,787

-51,620

-63,061

-85,616

-116,566

-47,713

-1,297

-40,908

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

23,129

24,896

26,639

28,921

31,307

33,112

33,448

33,135

32,127

31,145

29,796

27,789

26,324

24,572

23,198

22,059

19,842

17,743

15,747

14,000

12,159

10,415

8,614

7,284

7,139

7,205

0

0

0

Loss on disposals of assets, net

-2,795

-3,071

-18,693

-16,629

-21,105

-20,928

-5,923

-7,742

-2,874

-3,124

-1,680

-1,408

-1,047

-666

-411

-657

-726

-633

-557

-328

-293

-208

0

0

0

-

-

-

-

Gain on sale of discontinued operations

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on release of cumulative foreign currency translation adjustments to loss from discontinued operations

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized and realized (appreciation) depreciation on equity securities and preferred stock, net

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Equity Securities and Preferred Stock, Unrealized and Realized Appreciation (Depreciation)

7,657

7,833

-1

-4,220

-29,034

-30,200

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-10,469

-44,205

20,223

61,734

10,443

0

0

0

Noncash dividend income

-

-

-

-

-

14,841

19,028

18,690

17,713

16,756

16,048

15,401

11,347

7,421

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized (appreciation) depreciation on equity securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Amortization of discounts on investments, net

886

1,005

1,445

1,464

1,123

771

275

-81

-213

-411

-619

-802

-948

-1,070

-1,206

-1,044

-838

-642

-534

-761

-1,067

-1,357

-1,586

-1,457

-1,130

-716

0

0

0

Income (Loss) from Equity Method Investments

-5,479

-6,730

-6,762

-7,985

-10,788

-11,608

-12,890

-13,013

-11,796

-14,283

-15,442

-18,704

-20,424

-21,120

-19,330

-15,504

-12,631

-8,944

-8,315

-7,505

-6,680

-5,260

-3,726

-2,107

-752

-606

0

0

0

Gain on previously held equity investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,415

0

0

0

Stock-based compensation expense

14,268

18,950

22,494

25,203

33,988

36,296

37,967

41,892

45,044

41,576

43,520

42,255

36,908

42,202

42,774

40,367

41,596

38,667

33,501

29,366

28,334

21,849

15,952

12,347

6,308

2,921

0

0

0

Contribution of services by shareholder

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,991

1,872

1,752

1,632

1,550

0

0

0

Shares issued as payment for services

10,545

10,446

10,278

10,896

8,585

10,695

11,082

10,895

11,144

11,118

10,933

10,798

10,609

10,777

9,973

7,378

4,772

2,169

0

0

0

-

-

-

-

-

-

-

-

Shares issued to nonemployee members of the Board of Directors

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

Shares issued as consideration for license agreement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

59,579

59,579

59,579

59,579

0

0

0

0

-

-

-

-

Accounts Receivable, Credit Loss Expense (Reversal)

3,701

3,242

969

1,334

1,625

1,779

1,721

1,424

1,426

1,217

1,447

1,362

1,132

1,963

1,804

1,956

2,204

1,757

2,053

1,549

958

565

0

0

0

-

-

-

-

Accretion of debt discount and amortization of deferred financing costs

9,763

9,459

9,224

8,910

6,591

4,378

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred Income Tax Expense (Benefit)

-3,166

-3,674

-3,391

-17,170

-17,712

-21,278

-19,569

-6,098

-5,964

-2,528

-2,794

-2,327

-1,917

-3,467

-2,224

-2,494

-1,866

1,117

374

952

795

0

0

0

0

-

-

-

-

Other noncash items

-841

-837

-3,742

-4,054

-1,201

-1,093

-1,966

-3,294

244

517

1,445

2,335

-1,323

-1,662

-1,414

-309

-389

-460

-784

-1,194

-952

-723

0

0

0

-

-

-

0

Receivables:
Trade

1,130

262

2,856

2,802

3,248

2,698

1,352

1,197

-665

-740

-2,961

-3,349

-1,497

-2,588

-1,994

-112,915

8,301

12,138

11,125

123,166

-3,425

-4,332

-2,848

550

516

644

0

0

0

Related parties

592

-967

-6,108

-1,407

-7,858

-11,003

-7,789

-8,845

-10,354

-631

1,707

4,334

5,768

-6,804

-7,578

2,052

6,271

11,042

12,131

2,885

2,551

6,117

5,928

7,497

2,503

4,967

0

0

0

Notes

-

-

-

-

-

-

-

-

-

-

-

-

-

42

43

4

-4

0

0

21

17

1

0

0

0

-

-

-

-

Other

-438

656

-829

193

-315

542

785

52

413

-661

-427

-305

-1,298

-271

723

-5,702

-5,051

-5,286

-6,446

-346

-186

-15

11

479

664

542

0

0

0

Inventory

-3,921

-4,100

-1,720

-2,186

-672

478

178

905

1,164

-663

-2,542

-3,736

-4,380

-3,807

-458

-2,509

-1,093

774

4,444

8,525

7,695

7,313

0

0

0

-

-

-

-

Prepaid expenses and other

1,013

2,262

2,803

233

378

-1,006

-497

-1,305

-1,344

-492

463

1,760

865

932

-291

-239

2,294

2,729

3,791

1,899

759

465

398

1,329

454

347

0

0

0

Right-of-use assets

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

-327

-333

-27

652

-712

-652

-184

598

538

1,017

562

825

-824

-2,189

-3,832

-5,454

64

2,119

3,826

4,867

1,173

-80

-129

-7,600

23

18

0

0

0

Accounts payable

-5,029

-5,349

979

1,462

4,207

4,680

-377

-78

-3,176

-3,402

-3,039

-3,008

235

3,618

3,198

-304

-1,542

-3,263

-1,097

802

1,422

1,266

-1,422

-426

539

-43

0

0

0

Accrued compensation and benefits

5,033

5,186

-12,641

-3,559

-2,254

4,385

12,804

4,885

2,461

-1,466

-1,110

-1,613

-705

-12,402

-3,405

-3,151

15

10,491

6,937

6,833

3,770

1,587

2,013

691

-1,191

1,301

0

0

0

Other accrued liabilities

-2,361

-5,516

-6,886

-6,334

-3,300

356

3,044

-155

465

3,007

2,785

6,192

4,347

9,002

8,041

5,561

5,107

1,593

1,557

1,675

390

-586

1,038

97

1,750

1,558

0

0

0

Deferred revenue

-4,344

7,423

-10,529

-14,040

-27,625

-38,578

-63,049

-65,191

-71,949

-75,337

-46,663

-45,197

-41,542

-25,481

7,935

7,447

80,105

74,434

54,698

61,186

-4,871

20,934

20,359

13,978

18,760

-4,368

0

0

0

Lease liabilities

-1,077

-995

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Related party payables

-1,784

45

153

214

2,029

-52

-670

-630

-473

-147

187

263

263

310

482

-57,103

300

-64

-1,012

56,243

-1,246

-1,137

-221

85

-252

6

0

0

0

Other long-term liabilities

-

-

-

-

-

281

310

937

1,306

1,328

1,291

649

323

146

54

14

-82

96

242

156

-13

-160

-333

-367

-164

-249

0

0

0

Net cash used in operating activities

-120,436

-135,927

-141,147

-142,819

-137,586

-124,240

-120,758

-113,948

-108,919

-103,720

-87,048

-80,769

-70,068

-48,988

-19,448

49,178

45,101

35,669

14,287

-45,245

-42,378

-19,858

-21,032

-30,241

-29,925

-53,683

0

0

0

Cash flows from investing activities
Purchases of investments

174,340

55,073

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sales and maturities of investments

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Maturities of investments

-

-

-

-

-

-

0

0

135,542

-

166,300

148,000

128,987

101,987

89,987

81,987

82,000

88,000

94,747

97,245

111,743

122,992

0

0

0

-

-

-

0

Purchases of preferred stock and warrants

-

-

-

-

-

-

-

-

-

1,161

1,161

2,302

3,469

2,308

2,308

3,347

2,180

17,080

36,576

34,396

34,396

19,496

0

0

0

-

-

-

-

Proceeds from sales of equity securities

23,038

23,456

589

589

635

217

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisitions of businesses, net of cash received

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

123,928

114,940

102,166

92,224

67,577

67,112

4,907

4,907

-517

0

0

0

Investments in affiliates

3,343

3,713

6,156

10,442

11,442

16,582

14,689

15,120

12,120

11,189

12,766

11,067

13,400

11,542

18,158

15,162

14,672

13,442

5,469

4,709

2,866

2,875

0

0

0

-

-

-

0

Return of investment in affiliate

-

-

-

-

-

2,598

2,598

2,598

2,598

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid in asset acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

Purchases of property, plant and equipment

29,512

37,883

44,432

45,421

42,336

41,587

44,345

49,993

51,097

46,666

44,107

39,853

33,715

31,629

23,105

16,047

14,295

12,749

11,022

9,360

6,100

6,371

5,455

4,502

4,328

1,527

0

0

0

Proceeds from sale of assets

1,305

688

698

2,003

2,104

2,267

2,143

961

1,729

1,636

1,454

1,249

309

274

449

533

534

626

445

258

370

176

0

0

0

-

-

-

-

Proceeds from sale of discontinued operations, net of cash sold

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuances of notes receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,000

0

0

0

Proceeds from repayment of notes receivable

0

-

-

-

0

-

-

-

-

1,500

1,500

1,500

1,500

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from related party notes receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Net cash provided by (used in) investing activities

16,706

86,851

63,083

-111,728

-110,165

-151,213

-158,040

31,129

62,322

104,332

97,170

5,267

2,282

-28,392

-47,071

-222,813

-229,332

-259,245

-246,853

-47,094

-77,917

-26,029

-38,453

-125,096

-198,339

-223,663

0

0

0

Cash flows from financing activities
Cash flows from financing activities
Proceeds from issuance of shares in a private placement

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

25,000

0

0

0

-

-

-

0

Proceeds from issuance of shares and warrants in public offering, net of issuance costs

0

6,611

6,611

6,611

6,611

87,990

87,990

87,990

87,990

0

0

0

0

-

-

-

-

328,234

328,234

110,041

110,041

0

0

0

0

-

-

-

-

Acquisitions of noncontrolling interests

-

-

-

-

-

-

-

-

-

913

913

913

913

0

0

0

0

1,566

1,566

1,566

1,566

0

0

0

0

-

-

-

-

Advances from lines of credit

19,067

11,757

5,953

5,533

4,730

4,561

4,574

4,860

5,467

5,906

7,330

6,859

5,941

5,075

3,821

5,092

10,485

15,232

17,717

16,356

10,235

4,676

0

0

0

-

-

-

-

Repayments of advances from lines of credit

18,139

10,301

5,584

5,720

4,774

4,328

4,608

4,571

5,556

6,493

7,645

7,035

6,067

4,816

3,747

5,504

10,570

16,944

17,798

19,574

13,705

6,494

0

0

0

-

-

-

-

Proceeds from issuance of subscriptions payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Payments of capital lease obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

Proceeds from long-term debt, net of issuance costs

0

376

26,235

220,235

220,235

219,859

194,040

40

199

325

285

832

673

547

547

37

37

81

81

44

164

268

407

590

641

493

0

0

0

Payments of long-term debt

572

618

602

663

661

623

619

548

536

519

738

768

1,164

1,201

1,380

1,571

1,383

1,564

1,555

1,357

1,020

679

0

0

0

-

-

-

-

Payments of deferred consideration for acquisitions

-

-

-

-

-

-

-

-

-

8,678

8,678

8,696

8,696

6,705

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from stock option and warrant exercises

6

313

1,575

1,710

2,319

2,336

1,187

1,235

1,129

980

1,852

2,172

9,563

19,165

20,434

21,751

21,672

14,462

12,423

10,895

3,726

1,489

1,633

1,381

737

414

0

0

0

Payment of stock issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

10

0

0

0

0

-

-

-

-

256

256

256

1,877

3,148

0

0

0

Net cash provided by financing activities

35,362

8,138

34,188

227,743

228,460

309,795

296,250

95,968

95,692

4,284

-8,517

-7,559

-673

12,065

11,404

230,180

230,616

331,683

332,850

116,422

109,449

24,004

23,067

195,442

278,596

316,451

0

0

0

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

-345

-810

-1,126

-504

-1,123

295

741

972

1,443

1,055

332

-247

-435

-873

-611

-363

333

209

445

311

-191

-160

-100

-61

-4

1

0

0

0

Net decrease in cash, cash equivalents, and restricted cash

-68,713

-41,748

-45,002

-27,308

-20,414

34,637

18,193

14,121

50,538

5,951

1,937

-83,308

-68,894

-66,188

-55,726

56,182

46,718

108,316

100,729

24,394

-11,037

-22,043

-36,518

40,044

50,328

39,106

0

0

0

Supplemental Cash Flow Information [Abstract]
Cash paid during the period for interest

7,242

3,751

7,206

7,310

3,863

3,868

443

666

629

617

623

970

964

964

951

1,236

1,181

1,195

1,230

243

229

158

48

17

62

51

0

0

0

Cash paid during the period for income taxes

60

50

73

93

226

216

262

352

586

566

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Significant noncash activities
Accrued compensation paid in equity awards

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of dividends on redeemable convertible preferred shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18,391

0

0

0

Stock received as consideration for collaboration agreements

-

-

-

-

-

-

-

-

-

-

-

-

-

18,766

23,248

22,815

18,482

9,149

13,688

9,021

9,021

14,246

9,681

20,796

22,128

19,303

0

0

0

Stock and warrants issued in business combinations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

126,863

126,863

103,470

72,049

51,682

0

0

0

-

-

-

-

Stock issued to acquire noncontrolling interests

-

-

-

-

-

-

-

-

-

5,082

5,082

5,082

5,082

0

0

0

0

9,412

9,412

9,412

9,412

0

0

0

0

-

-

-

-

Stock issued in asset acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

4,401

4,401

4,401

4,401

0

0

0

0

-

-

-

-

-

-

-

-

Contingent consideration assumed in asset acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

3,660

3,660

3,660

3,660

0

0

0

0

-

-

-

-

-

-

-

-

Noncash dividend to shareholders

-

-

-

-

-

-

-

-

-

22,385

22,385

22,385

22,385

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment included in accounts payable and other accrued liabilities

-1,468

694

871

1,226

2,782

2,267

2,208

746

3,141

2,257

1,863

3,096

945

652

1,175

836

1,621

782

0

0

0

-

-

-

-

-

-

-

-

Cash, cash equivalents, and restricted cash
Purchases of equipment financed through debt

-

-

-

-

-

234

193

76

76

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from stock option exercises included in other receivables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

Stock issued and payable in Medistem, Inc. acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0